D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snap
SNAP
|
+$362M |
| 2 |
Lockheed Martin
LMT
|
+$361M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$354M |
| 4 |
Fidelity National Information Services
FIS
|
+$354M |
| 5 |
Boston Scientific
BSX
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$559M |
| 2 |
Advanced Micro Devices
AMD
|
+$558M |
| 3 |
Boeing
BA
|
+$530M |
| 4 |
Lowe's Companies
LOW
|
+$525M |
| 5 |
Alibaba
BABA
|
+$420M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.37% |
| 2 | Consumer Discretionary | 10.41% |
| 3 | Healthcare | 8.95% |
| 4 | Communication Services | 6.76% |
| 5 | Financials | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Healthpeak Properties
DOC
$15.2B
| $13.8M | 0.01% |
455,035
-407,480
| -47% | -$11.9M |
|
1102
CubeSmart
CUBE
$9.34B
| $13.7M | 0.01% |
+406,840
| New | +$13.6M |
|
1103
CALL
Fiverr
FVRR
$330M
| $13.7M | 0.01% |
70,000
+30,000
| +75% | +$5.43M |
|
1104
Axsome Therapeutics
AXSM
$12.1B
| $13.6M | 0.01% |
167,182
-64,060
| -28% | -$4.79M |
|
1105
Broadcom
AVGO
$1.85T
| $13.5M | 0.01% |
308,610
-40,490
| -12% | -$1.58M |
|
1106
PUT
Humana
HUM
$44B
| $13.5M | 0.01% |
32,900
| – | – |
|
|
XLNX
1107
PUT
DELISTED
Xilinx Inc
XLNX
| $13.5M | 0.01% |
95,100
| – | – |
|
1108
Black Hills Corp
BKH
$5.5B
| $13.5M | 0.01% |
219,252
-42,124
| -16% | -$2.52M |
|
1109
Altimmune
ALT
$580M
| $13.5M | 0.01% |
1,193,694
-467,136
| -28% | -$5.5M |
|
1110
Lamar Advertising Co
LAMR
$16.3B
| $13.4M | 0.01% |
161,293
-273,224
| -63% | -$20.4M |
|
1111
Akamai
AKAM
$16.5B
| $13.4M | 0.01% |
127,585
-342,198
| -73% | -$35.8M |
|
1112
Amdocs
DOX
$5.87B
| $13.4M | 0.01% |
188,575
-423,585
| -69% | -$26.6M |
|
|
MRC
1113
DELISTED
MRC Global
MRC
| $13.4M | 0.01% |
2,017,541
+17,090
| +0.9% | +$94.3K |
|
1114
PUT
Equinix
EQIX
$103B
| $13.4M | 0.01% |
+18,700
| New | +$13.9M |
|
1115
Cerus
CERS
$579M
| $13.3M | 0.01% |
1,927,884
+234,611
| +14% | +$1.54M |
|
1116
Progress Software
PRGS
$1.65B
| $13.3M | 0.01% |
294,982
-58,225
| -16% | -$2.35M |
|
|
CYBR
1117
CALL
DELISTED
CyberArk
CYBR
| $13.3M | 0.01% |
82,200
+29,100
| +55% | +$3.39M |
|
1118
PROG Holdings
PRG
$1.72B
| $13.3M | 0.01% |
+246,010
| New | +$12.7M |
|
1119
Freshpet
FRPT
$2.98B
| $13.2M | 0.01% |
93,307
-958
| -1% | -$124K |
|
|
1120
PUT
Lowe's Companies
LOW
$118B
| $13.2M | 0.01% |
82,400
+55,900
| +211% | +$9.08M |
|
1121
Tradeweb Markets
TW
$20.8B
| $13.2M | 0.01% |
211,571
+8,652
| +4% | +$523K |
|
|
ONC
1122
BeOne Medicines Ltd
ONC
$33.4B
| $13.2M | 0.01% |
+51,120
| New | +$14.1M |
|
1123
Arcosa
ACA
$7.13B
| $13.2M | 0.01% |
240,440
-11,941
| -5% | -$609K |
|
1124
WaFd
WAFD
$2.69B
| $13.2M | 0.01% |
512,464
+188,582
| +58% | +$4.49M |
|
1125
Integra LifeSciences
IART
$1.33B
| $13.2M | 0.01% |
203,143
-129,294
| -39% | -$6.96M |
|
Similar funds
D.E. Shaw & Co's Q4 2020 Portfolio in Review
As of Q4 2020, D.E. Shaw & Co held 4,343 positions worth $112B, up 14% from $97.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $10.3B in Q4 2020, closing 477 positions and reducing 1,508 holdings. Its most notable exit was iShares Gold Trust, an estimated $217M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Snowflake worth $147M.
- D.E. Shaw & Co's largest Q4 2020 buy was Snowflake: 523,721 shares worth $147M.
- D.E. Shaw & Co added most to Snap in Q4 2020, an estimated $362M increase.
- D.E. Shaw & Co's biggest Q4 2020 reduction was Tesla, cutting an estimated $559M.
- D.E. Shaw & Co fully exited iShares Gold Trust in Q4 2020, selling an estimated $217M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $112B portfolio in Q4 2020.
- D.E. Shaw & Co opened 563 new positions and closed 477 in Q4 2020.
- D.E. Shaw & Co's portfolio value rose 14% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q4 2020, filed 16 Feb 2021.